Cargando…
Trévo abrogates Lead Acetate Neurotoxicity in Male Wistar Rats viz Antiamyloidogenesis, Antiglutaminergic, and Anticholinesterase Activities
BACKGROUND: Exposure to lead has been linked to biochemical changes similar to those patients suffering from Alzheimer’s disease. Trévo is a phytonutrient-rich product with antiaging and antioxidant properties. PURPOSE: To investigate the neuroprotective activity of trévo against lead-induced bioche...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9676341/ https://www.ncbi.nlm.nih.gov/pubmed/36419514 http://dx.doi.org/10.1177/09727531221077642 |
_version_ | 1784833575838810112 |
---|---|
author | Ilesanmi, Omotayo B. Odewale, Temitope Temiloluwa Avwioroko, Oghenetega J. Ahmed, Eman Ibrahim Alaneme, Chinenyenwa Atanu, Francis O. Chikere, Bruno James, Millicent Chinagor, Innocent Albezrah, Nisreen Khalid Aref Youssef, Amal Binang, Toyin Batiha, Gaber El-Saber |
author_facet | Ilesanmi, Omotayo B. Odewale, Temitope Temiloluwa Avwioroko, Oghenetega J. Ahmed, Eman Ibrahim Alaneme, Chinenyenwa Atanu, Francis O. Chikere, Bruno James, Millicent Chinagor, Innocent Albezrah, Nisreen Khalid Aref Youssef, Amal Binang, Toyin Batiha, Gaber El-Saber |
author_sort | Ilesanmi, Omotayo B. |
collection | PubMed |
description | BACKGROUND: Exposure to lead has been linked to biochemical changes similar to those patients suffering from Alzheimer’s disease. Trévo is a phytonutrient-rich product with antiaging and antioxidant properties. PURPOSE: To investigate the neuroprotective activity of trévo against lead-induced biochemical changes in male Wistar rats. METHODS: The study involves 35 animals that were randomly divided into five groups of seven rats each. Group I (Control): Orally administered distilled water; Group II (Induced): Administered 15 mg/kg of lead acetate (PbA) intraperitoneally; Group III (Treatment group): Orally administered 2 mL/kg of trévo for two days before co-administration with PbA for 12 consecutive days; Group IV (Treatment group): Orally administered 5 mL/kg of trévo for two days prior to coadministration with PbA for 12 consecutive days; Group V: Orally administered 5 mL/kg of trévo for 14 consecutive days. Animals were anesthetized with diether and the brain excised and processed for the following biochemical assays: Malonedialdehyde (MDA), glutathione (GSH), catalase (CAT), superoxide dismutase (SOD), glutathione-S-transferase (GT), acetylcholinesterase (AChE), beta-amyloid, glutamate, Na+/K+ ATPase, and glutamate dehydrogenase (GD). RESULTS: PbA caused significant oxidative stress (increased MDA concentration, decreased GSH concentration, suppressed the activity of CAT, SOD), decreased GT activity, increased activity of AChE, increased the concentration of beta-amyloid, and caused glutamate excitotoxicity (increased concentration of glutamate, decreased activity of Na+/K+ ATPase, and GD) in rat brains. Treatment with trévo at the two different doses significantly prevented oxidative damage, beta-amyloid aggregation, glutamate excitotoxicity, and acetylcholine breakdown induced by lead acetate. CONCLUSION: Our findings added to the reported pharmacological activity of trévo and supported the antiaging potential of trévo. |
format | Online Article Text |
id | pubmed-9676341 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-96763412022-11-22 Trévo abrogates Lead Acetate Neurotoxicity in Male Wistar Rats viz Antiamyloidogenesis, Antiglutaminergic, and Anticholinesterase Activities Ilesanmi, Omotayo B. Odewale, Temitope Temiloluwa Avwioroko, Oghenetega J. Ahmed, Eman Ibrahim Alaneme, Chinenyenwa Atanu, Francis O. Chikere, Bruno James, Millicent Chinagor, Innocent Albezrah, Nisreen Khalid Aref Youssef, Amal Binang, Toyin Batiha, Gaber El-Saber Ann Neurosci Original Articles BACKGROUND: Exposure to lead has been linked to biochemical changes similar to those patients suffering from Alzheimer’s disease. Trévo is a phytonutrient-rich product with antiaging and antioxidant properties. PURPOSE: To investigate the neuroprotective activity of trévo against lead-induced biochemical changes in male Wistar rats. METHODS: The study involves 35 animals that were randomly divided into five groups of seven rats each. Group I (Control): Orally administered distilled water; Group II (Induced): Administered 15 mg/kg of lead acetate (PbA) intraperitoneally; Group III (Treatment group): Orally administered 2 mL/kg of trévo for two days before co-administration with PbA for 12 consecutive days; Group IV (Treatment group): Orally administered 5 mL/kg of trévo for two days prior to coadministration with PbA for 12 consecutive days; Group V: Orally administered 5 mL/kg of trévo for 14 consecutive days. Animals were anesthetized with diether and the brain excised and processed for the following biochemical assays: Malonedialdehyde (MDA), glutathione (GSH), catalase (CAT), superoxide dismutase (SOD), glutathione-S-transferase (GT), acetylcholinesterase (AChE), beta-amyloid, glutamate, Na+/K+ ATPase, and glutamate dehydrogenase (GD). RESULTS: PbA caused significant oxidative stress (increased MDA concentration, decreased GSH concentration, suppressed the activity of CAT, SOD), decreased GT activity, increased activity of AChE, increased the concentration of beta-amyloid, and caused glutamate excitotoxicity (increased concentration of glutamate, decreased activity of Na+/K+ ATPase, and GD) in rat brains. Treatment with trévo at the two different doses significantly prevented oxidative damage, beta-amyloid aggregation, glutamate excitotoxicity, and acetylcholine breakdown induced by lead acetate. CONCLUSION: Our findings added to the reported pharmacological activity of trévo and supported the antiaging potential of trévo. SAGE Publications 2022-03-04 2022-04 /pmc/articles/PMC9676341/ /pubmed/36419514 http://dx.doi.org/10.1177/09727531221077642 Text en © 2022 Indian Academy of Neurosciences (IAN) https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Original Articles Ilesanmi, Omotayo B. Odewale, Temitope Temiloluwa Avwioroko, Oghenetega J. Ahmed, Eman Ibrahim Alaneme, Chinenyenwa Atanu, Francis O. Chikere, Bruno James, Millicent Chinagor, Innocent Albezrah, Nisreen Khalid Aref Youssef, Amal Binang, Toyin Batiha, Gaber El-Saber Trévo abrogates Lead Acetate Neurotoxicity in Male Wistar Rats viz Antiamyloidogenesis, Antiglutaminergic, and Anticholinesterase Activities |
title | Trévo abrogates Lead Acetate Neurotoxicity in Male Wistar Rats viz Antiamyloidogenesis, Antiglutaminergic, and Anticholinesterase Activities |
title_full | Trévo abrogates Lead Acetate Neurotoxicity in Male Wistar Rats viz Antiamyloidogenesis, Antiglutaminergic, and Anticholinesterase Activities |
title_fullStr | Trévo abrogates Lead Acetate Neurotoxicity in Male Wistar Rats viz Antiamyloidogenesis, Antiglutaminergic, and Anticholinesterase Activities |
title_full_unstemmed | Trévo abrogates Lead Acetate Neurotoxicity in Male Wistar Rats viz Antiamyloidogenesis, Antiglutaminergic, and Anticholinesterase Activities |
title_short | Trévo abrogates Lead Acetate Neurotoxicity in Male Wistar Rats viz Antiamyloidogenesis, Antiglutaminergic, and Anticholinesterase Activities |
title_sort | trévo abrogates lead acetate neurotoxicity in male wistar rats viz antiamyloidogenesis, antiglutaminergic, and anticholinesterase activities |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9676341/ https://www.ncbi.nlm.nih.gov/pubmed/36419514 http://dx.doi.org/10.1177/09727531221077642 |
work_keys_str_mv | AT ilesanmiomotayob trevoabrogatesleadacetateneurotoxicityinmalewistarratsvizantiamyloidogenesisantiglutaminergicandanticholinesteraseactivities AT odewaletemitopetemiloluwa trevoabrogatesleadacetateneurotoxicityinmalewistarratsvizantiamyloidogenesisantiglutaminergicandanticholinesteraseactivities AT avwiorokooghenetegaj trevoabrogatesleadacetateneurotoxicityinmalewistarratsvizantiamyloidogenesisantiglutaminergicandanticholinesteraseactivities AT ahmedemanibrahim trevoabrogatesleadacetateneurotoxicityinmalewistarratsvizantiamyloidogenesisantiglutaminergicandanticholinesteraseactivities AT alanemechinenyenwa trevoabrogatesleadacetateneurotoxicityinmalewistarratsvizantiamyloidogenesisantiglutaminergicandanticholinesteraseactivities AT atanufranciso trevoabrogatesleadacetateneurotoxicityinmalewistarratsvizantiamyloidogenesisantiglutaminergicandanticholinesteraseactivities AT chikerebruno trevoabrogatesleadacetateneurotoxicityinmalewistarratsvizantiamyloidogenesisantiglutaminergicandanticholinesteraseactivities AT jamesmillicent trevoabrogatesleadacetateneurotoxicityinmalewistarratsvizantiamyloidogenesisantiglutaminergicandanticholinesteraseactivities AT chinagorinnocent trevoabrogatesleadacetateneurotoxicityinmalewistarratsvizantiamyloidogenesisantiglutaminergicandanticholinesteraseactivities AT albezrahnisreenkhalidaref trevoabrogatesleadacetateneurotoxicityinmalewistarratsvizantiamyloidogenesisantiglutaminergicandanticholinesteraseactivities AT youssefamal trevoabrogatesleadacetateneurotoxicityinmalewistarratsvizantiamyloidogenesisantiglutaminergicandanticholinesteraseactivities AT binangtoyin trevoabrogatesleadacetateneurotoxicityinmalewistarratsvizantiamyloidogenesisantiglutaminergicandanticholinesteraseactivities AT batihagaberelsaber trevoabrogatesleadacetateneurotoxicityinmalewistarratsvizantiamyloidogenesisantiglutaminergicandanticholinesteraseactivities |